Patent · US Active

Compositions and methods for treating anxiety-related disorders

US11931329B2 · kind B2 · utility

0Cited by
1References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 4, 2022
Grant dateMar 19, 2024
Priority date
Expiry dateAug 4, 2042

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/22
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides methods, compositions, and kits for treating anxiety-related disorders, including OCD and SAD, and for reducing anxiety, obsessive behavior, or compulsive behavior in subjects in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.